Helius Medical Operating Cash Flow Sales Ratio Over Time
| HSDT Stock | USD 0.49 0.03 6.52% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Helius Medical Performance and Helius Medical Correlation. Helius |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Helius Medical. If investors know Helius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Helius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.27) | Revenue Per Share 0.512 | Quarterly Revenue Growth (0.29) | Return On Assets (0.76) | Return On Equity (1.62) |
The market value of Helius Medical Techn is measured differently than its book value, which is the value of Helius that is recorded on the company's balance sheet. Investors also form their own opinion of Helius Medical's value that differs from its market value or its book value, called intrinsic value, which is Helius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Helius Medical's market value can be influenced by many factors that don't directly affect Helius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Helius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Helius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Helius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Cash Flow Sales Ratio Analysis
Compare Helius Medical Techn and related stocks such as Nuwellis, ReShape Lifesciences, and Bone Biologics Corp Operating Cash Flow Sales Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NUWE | (52.8947) | (294) | (294) | (294) | (76.7593) | (390) | (12.6393) | (3.3549) | (2.9132) | (2.9699) | (2.2271) | (2.2573) | (1.7733) | (2.0236) | (2.12) |
| RSLS | (72.0493) | (72.0493) | (72.0493) | (77.4179) | (77.4179) | (77.4179) | (26.2576) | (19.1028) | (45.3102) | (0.9411) | (0.7567) | (1.1305) | (1.9486) | (1.9544) | (2.05) |
| BBLG | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| SINT | (0.7358) | (0.7358) | (0.4219) | (0.4459) | (0.6379) | (0.4659) | (0.4709) | (0.4169) | (98.4) | (9.3396) | (15.3401) | (16.7195) | (17.0765) | (5.373) | (5.64) |
| TIVC | (8.7381) | (8.7381) | (8.7381) | (8.7381) | (8.7381) | (8.7381) | (8.7381) | (8.7381) | (8.7381) | (8.7381) | (3.5198) | (4.813) | (4.8473) | (7.2372) | (7.6) |
| BJDX | (31.0857) | (31.0857) | (31.0857) | (31.0857) | (31.0857) | (31.0857) | (31.0857) | (31.0857) | (31.0857) | (31.0857) | (31.0857) | (31.0857) | (31.0857) | (27.98) | (29.38) |
| HSCS | (59.8298) | (59.8298) | (59.8298) | (59.8298) | (59.8298) | (59.8298) | (59.8298) | (59.8298) | (59.8298) | (59.8298) | (95.7778) | (254) | (1.1 K) | (326) | (343) |
| VVOS | (1.4012) | (1.4012) | (1.4012) | (1.4012) | (1.4012) | (1.4012) | (1.4012) | (1.4012) | (1.4012) | (0.4687) | (0.4347) | (0.9319) | (1.2224) | (0.8656) | (0.91) |
| RPID | (1.2807) | (1.2807) | (1.2807) | (1.2807) | (1.2807) | (1.2807) | (1.2807) | (1.2807) | (1.2807) | (1.2807) | (1.928) | (2.3659) | (3.4172) | (2.0019) | (2.1) |
| SSKN | (69.0354) | (69.0354) | (69.0354) | (36.2183) | (19.3541) | (0.356) | 0.0101 | 0.1316 | 0.097 | 0.0706 | 0.0908 | 0.0503 | (0.0306) | (0.0156) | (0.0163) |
| SGHT | (1.9223) | (1.9223) | (1.9223) | (1.9223) | (1.9223) | (1.9223) | (1.9223) | (1.9223) | (1.9223) | (1.0706) | (1.164) | (1.0732) | (1.065) | (0.5821) | (0.61) |
Helius Medical Techn and related stocks such as Nuwellis, ReShape Lifesciences, and Bone Biologics Corp Operating Cash Flow Sales Ratio description
My Equities
My Current Equities and Potential Positions
| Helius Medical Technologies | HSDT |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Pennsylvania; U.S.A |
| Exchange | NASDAQ Exchange |
USD 0.49
Additional Tools for Helius Stock Analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.